Progressive Familial Intrahepatic Cholestasis: A Descriptive Study in a Tertiary Care Center

Table 6

Recurrence of the disease after LT in 4 patients with PFIC type 2.

	Clinical recurrence after liver transplantation (months)	Treatment provided	Response to treatment (yes/no)	Retransplantation
Patient 1	18	Plasmapheresis (5 cycles)	Yes	No
		IVIG (5 doses)
		Rituximab (4 doses)
Patient 2	1	Antithymocyte globulins (4 doses)	No	Listed for retransplantation
		Plasmapheresis (5 cycles)
		Rituximab (5 cycles)
Patient 3	16	Rituximab, IVIG, plasmapheresis	Yes	No
Patient 4	55	Plasmapheresis (5 cycles)	Yes	No
		IVIG (3 doses)
		Rituximab (3 doses)